BALDUZZI, Sara
 Distribuzione geografica
Continente #
NA - Nord America 5.097
EU - Europa 2.443
AS - Asia 1.752
SA - Sud America 303
AF - Africa 36
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 9.639
Nazione #
US - Stati Uniti d'America 5.035
GB - Regno Unito 900
SG - Singapore 553
CN - Cina 507
IT - Italia 409
HK - Hong Kong 272
SE - Svezia 266
BR - Brasile 252
DE - Germania 201
IE - Irlanda 171
VN - Vietnam 125
RU - Federazione Russa 93
UA - Ucraina 83
FR - Francia 67
FI - Finlandia 63
TR - Turchia 48
ID - Indonesia 47
IN - India 43
KR - Corea 41
BG - Bulgaria 35
CA - Canada 33
NL - Olanda 27
BE - Belgio 24
MX - Messico 20
JP - Giappone 18
AR - Argentina 17
ES - Italia 15
PL - Polonia 15
ZA - Sudafrica 13
AT - Austria 11
BD - Bangladesh 11
LT - Lituania 10
GR - Grecia 9
MK - Macedonia 9
MY - Malesia 9
PH - Filippine 9
PK - Pakistan 8
CL - Cile 7
EC - Ecuador 7
JO - Giordania 7
VE - Venezuela 7
CH - Svizzera 6
CZ - Repubblica Ceca 6
DK - Danimarca 6
IL - Israele 6
NP - Nepal 6
UZ - Uzbekistan 6
IQ - Iraq 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
BH - Bahrain 4
CO - Colombia 4
IR - Iran 4
KE - Kenya 4
MA - Marocco 4
PY - Paraguay 4
RO - Romania 4
BO - Bolivia 3
CY - Cipro 3
DZ - Algeria 3
ET - Etiopia 3
NO - Norvegia 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BN - Brunei Darussalam 2
BW - Botswana 2
EE - Estonia 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LY - Libia 2
OM - Oman 2
PE - Perù 2
RS - Serbia 2
TN - Tunisia 2
AD - Andorra 1
AM - Armenia 1
AP - ???statistics.table.value.countryCode.AP??? 1
BB - Barbados 1
BS - Bahamas 1
BZ - Belize 1
DO - Repubblica Dominicana 1
EG - Egitto 1
EU - Europa 1
GP - Guadalupe 1
HN - Honduras 1
IM - Isola di Man 1
IS - Islanda 1
KZ - Kazakistan 1
LB - Libano 1
LI - Liechtenstein 1
MD - Moldavia 1
PA - Panama 1
PT - Portogallo 1
SN - Senegal 1
TJ - Tagikistan 1
TM - Turkmenistan 1
ZM - Zambia 1
Totale 9.639
Città #
Southend 661
Fairfield 582
Santa Clara 467
Ashburn 462
Singapore 373
Woodbridge 327
Chandler 311
Hong Kong 270
Houston 233
Seattle 215
Ann Arbor 192
Wilmington 176
Dublin 170
Dearborn 162
Cambridge 160
Nyköping 147
Beijing 144
Jacksonville 126
London 105
Hefei 103
Chicago 88
New York 85
Los Angeles 82
Modena 75
Dallas 52
San Diego 52
The Dalles 41
Ho Chi Minh City 40
Jakarta 39
Bologna 38
Munich 37
Shanghai 37
Princeton 35
Hanoi 34
Sofia 34
Council Bluffs 32
Eugene 32
Moscow 32
Helsinki 31
Redwood City 28
São Paulo 28
Boardman 27
Milan 27
Salt Lake City 27
Seoul 27
Elk Grove Village 23
Izmir 22
Brussels 20
Buffalo 20
Columbus 20
Bremen 19
Rome 19
Tampa 19
Fremont 18
San Francisco 17
Phoenix 15
Turin 15
Frankfurt am Main 14
Warsaw 14
Dong Ket 13
Norwalk 13
San Jose 13
Brooklyn 12
Sterling 12
Tokyo 11
Mexico City 10
Paris 10
Redondo Beach 10
Reggio Emilia 10
Ottawa 9
Seongnam 9
Turku 9
Orem 8
Atlanta 7
Hillsboro 7
Istanbul 7
Montreal 7
Nanjing 7
Rio de Janeiro 7
Toronto 7
Amman 6
Amsterdam 6
Brasília 6
Changchun 6
Cleveland 6
Falls Church 6
Guangzhou 6
Poplar 6
Stockholm 6
Biên Hòa 5
Carpi 5
Chennai 5
Curitiba 5
Johannesburg 5
Kent 5
Kilburn 5
Miami 5
Monza 5
Roggiano Gravina 5
Tashkent 5
Totale 7.008
Nome #
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial 428
Indicators of Complex Care During the Consultation-Liaison Psychiatry Activity at the Transplant Center of the Policlinico Hospital, Modena 397
Non-steroid agents for idiopathic pulmonary fibrosis 389
Impact of time to surgery after neoadjuvant chemotherapy in operable breast cancer patients 360
The impact of shift work on the psychological and physical health of nurses in a general hospital: a comparison between rotating night shifts and day shifts 360
Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis. 352
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study. 339
Efficacy of a multiple-component and multifactorial personalized fall prevention program in a mixed population of community-dwelling older adults with stroke, Parkinson's Disease, or frailty compared to usual care: The PRE.C.I.S.A. randomized controlled trial 312
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy: Results of the phase III multicentric Italian study Short-HER 309
Short-term and long-term effects of tibolone in postmenopausal women 305
Impact of body composition parameters on tumor response to neoadjuvant chemotherapy in operable breast cancer patients. 298
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial . 294
Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer. 275
"the More the Better" Paradox of Antenatal Ultrasound Examinations in Low-Risk Pregnancy 272
3* Final analysis of the phase III multicentric Italian study Short-HER: 9 weeks vs 1 year adjuvant trastuzumab for HER2+ early breast cancer 271
Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV 265
Clinical differences in sarcoidosis patients with and without lymphoma: a single-center retrospective cohort analysis. 259
Home Oxygen Saturation Monitoring And Quality Of Life Evaluation In Patients With Idiopathic Pulmonary Fibrosis: Preliminary Results From A Prospective Multicenter Trial 258
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis 255
Safety and efficacy of T-DM1 in HER2 positive metastatic breast cancer patients: a real word experience. 249
Systematic review of maternal voice interventions demonstrates increased stability in preterm infants 241
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 239
Quantiferon-TB Gold In-Tube Tests In Hospital Health Care Workers: A Five Years Experience 237
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 237
9 weeks versus 1 year adjuvant trastuzumab for HER2+ early breast cancer: Subgroup analysis of the ShortHER trial allows to identify patients for whom a shorter trastuzumab administration may have a favourable risk/benefit ratio 227
Trastuzumab containing regimens for early breast cancer. 224
Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy. 222
Impact of anaemia on tumor response to neoadjuvant chemotherapy in breast cancer patients . 211
Short and long term effects of tibolone in postmenopausal women 210
Trastuzumab-containing regimens for metastatic breast cancer 207
Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter Analysis 201
Effectiveness of support groups to improve the quality of life of people with idiopathic pulmonary fibrosis a pre-post test pilot study 196
Repeated Quantiferon-TB Gold In-Tube Tests In Routine Clinical Practice: A Five Years Experience 189
Erlotinib for advanced pancreatic cancer 153
Outpatient parents' views on shared-decision-making at an Italian children's hospital 132
Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancer 120
Pattern of distant relapse according to intrinsic molecular subtype in patients with HER2-positive breast cancer: a combined analysis of ShortHER, CherLOB, and two institutional cohorts 114
Nine-Week Versus One-Year Trastuzumab for Early Human Epidermal Growth Factor Receptor 2â € "Positive Breast Cancer: 10-Year Update of the ShortHER Phase III Randomized Trial 108
Interaction between tumor-infiltrating lymphocytes and BMI in early HER2-positive breast cancer: analysis of the ShortHER trial. 3
Tumor-Infiltrating Lymphocytes and Survival Outcomes in Early ERBB2-Positive Breast Cancer: 10-Year Analysis of the ShortHER Randomized Clinical Trial. 2
Totale 9.720
Categoria #
all - tutte 36.882
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.882


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021698 0 0 0 0 0 86 88 129 79 157 115 44
2021/2022819 46 47 97 43 27 49 33 57 91 82 157 90
2022/20231.033 95 123 72 92 94 100 26 94 261 13 18 45
2023/2024622 21 28 46 53 103 59 80 63 23 39 43 64
2024/20251.858 57 25 38 110 371 321 148 117 170 76 179 246
2025/20261.790 235 101 260 377 654 163 0 0 0 0 0 0
Totale 9.720